Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes

BACKGROUND: The remedē System Pivotal Trial was a prospective, multi-center, randomized trial demonstrating transvenous phrenic nerve stimulation (TPNS) therapy is safe and effectively treats central sleep apnea (CSA) and improves sleep architecture and daytime sleepiness. Subsequently, the remedē S...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Sci Sleep
Main Authors: Costanzo, Maria Rosa, Javaheri, Shahrokh, Ponikowski, Piotr, Oldenburg, Olaf, Augostini, Ralph, Goldberg, Lee R, Stellbrink, Christoph, Fox, Henrik, Schwartz, Alan R, Gupta, Sanjaya, McKane, Scott, Meyer, Timothy E, Abraham, William T
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2021
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8092633/
https://ncbi.nlm.nih.gov/pubmed/33953626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NSS.S300713
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares